ANDREZA MAIA PEREIRA

Dr. ANDREZA MAIA PEREIRA

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2026 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
MLMarcio Luciano
Marcio Luciano
SSSergio Luis Schmidt
Sergio Luis Schmidt
EDEelco van Duinkerken
Eelco van Duinkerken
APANDREZA MAIA PEREIRA
ANDREZA MAIA PEREIRA
ACAna Luiza Coutinho
Ana Luiza Coutinho
Kai-Uwe LewandrowskiKai-Uwe Lewandrowski
Kai-Uwe Lewandrowski
Background: Obstructive sleep apnea (OSA) is associated with slower response speed, yet conventional severity classification based on the apnea–hypopnea index (AHI) shows limited ability to predict cognitive outcomes. The AHI aggregates distinct pathophysiological processes, including intermittent hypoxemia and sleep fragmentation. Within emerging precision sleep medicine frameworks, disentangling these mechanisms is critical for improved phenotyping and personalized risk assessment. This study aimed to replicate prior findings using a Go/No-Go Continuous Visual Attention Test (CVAT) and to identify the most informative polysomnographic predictor of attentional performance in OSA. Methods: In this cross-sectional study, participants underwent full-night type I polysomnography and the CVAT. After exclusions, 84 patients with OSA and 22 polysomnographically normal controls were analyzed. The sample sizes for mean differences and correlational analyses were adequate. Attentional performance was indexed by standardized reaction time (RT), referenced to a normative database (n = 1244). Within the OSA group, linear regression with backward elimination evaluated hypoxemia and sleep fragmentation metrics. Results: Patients with OSA demonstrated significantly slower RTs than controls (p = 0.005). Within OSA, the AHI was not associated with attentional performance (p = 0.398). In the final regression model, sleep stage shifts—reflecting sleep–wake instability—emerged as the sole independent predictor of attentional slowing (β = 0.27, p = 0.013), whereas all hypoxemia indices were excluded. Conclusions: Sleep stage instability represents a cognitive vulnerability marker in OSA, independent of respiratory events. Integrating fragmentation metrics into precision sleep medicine models may enhance individualized phenotyping, identify patients at higher neurocognitive risk, and inform targeted interventions focused on stabilizing sleep architecture rather than relying solely on the AHI.

22 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MLMarcio Luciano
Marcio Luciano
SSSergio Luis Schmidt
Sergio Luis Schmidt
EDEelco van Duinkerken
Eelco van Duinkerken
APANDREZA MAIA PEREIRA
ANDREZA MAIA PEREIRA
ACAna Luiza Coutinho
Ana Luiza Coutinho
Kai-Uwe LewandrowskiKai-Uwe Lewandrowski
Kai-Uwe Lewandrowski
Background: Obstructive sleep apnea (OSA) is associated with slower response speed, yet conventional severity classification based on the apnea–hypopnea index (AHI) shows limited ability to predict cognitive outcomes. AHI aggregates distinct pathophysiological processes intermittent hypoxemia and sleep fragmentation. Within emerging precision sleep medicine frameworks, disentangling these mechanisms is critical for improved phenotyping and personalized risk assessment. This study aimed to replicate prior findings using a Go/No-Go Continuous Visual Attention Test (CVAT) and to identify the most informative polysomnographic predictor of attentional performance in OSA. Methods: All participants underwent full-night type I polysomnography and a 15-minute Go/No-Go CVAT. After exclusions, 84 patients with OSA and 22 polysomnographically normal controls were analyzed. Attentional performance was indexed by standardized reaction time (Z-score), referenced to a normative database (n = 1,244). Within the OSA group, multiple linear regression with backward elimination evaluated hypoxemia and sleep fragmentation metrics. Results: Patients with OSA demonstrated significantly slower reaction times than controls (p = 0.005). Within OSA, AHI was not associated with attentional performance (p = 0.398). In the final regression model, sleep stage shifts—reflecting sleep–wake instability—emerged as the sole independent predictor of attentional slowing (β = 0.27, p = 0.013), whereas all hypoxemia indices were excluded. Conclusions: Sleep-stage instability represents a key cognitive vulnerability marker in OSA, independent of respiratory event burden. Integrating sleep fragmentation metrics into precision sleep medicine models may enhance individualized phenotyping, identify patients at higher neurocognitive risk, and inform targeted interventions focused on stabilizing sleep architecture rather than relying solely on AHI-based severity classification.

8 July 2026 in Crohn's & Colitis 360
Verified
Journal Article
Open access
APANDREZA MAIA PEREIRA
ANDREZA MAIA PEREIRA
JSJuliana SCHMIDT
Juliana SCHMIDT
CMCarlos Eduardo Brandão Mello
Carlos Eduardo Brandão Mello
GSGuilherme Janeiro Schmidt
Guilherme Janeiro Schmidt
YTYolanda Faia Manhães Tolentino
Yolanda Faia Manhães Tolentino
SSSergio Luis Schmidt
Sergio Luis Schmidt
Background: Behavioral and cognitive manifestations have been increasingly recognized in Crohn disease (CD), yet the specific behavioral domains associated with clinical activity remain incompletely characterized. Although reduced response speed has been proposed as a key feature, moment-to-moment fluctuations in performance may better capture behavioral instability related to systemic inflammation. We examined behavioral variability and attentional performance in CD and their relationship with clinical activity. Methods: In this case–control study, patients with CD of at least 1 year’s duration (n = 31) and healthy controls (n = 37) completed a short, computerized attention test assessing sustained-attention, focused-attention, inhibitory control, and processing speed. Group differences were evaluated using multivariate and univariate analyses of covariance. Binary logistic regression evaluated the discriminative ability of attentional measures, while correlations and regression analyses examined associations with disease activity measured by the Harvey-Bradshaw Index (HBI). Results: Fifty percent of patients with CD were in clinical remission. Compared with controls, patients with CD demonstrated significantly greater attentional variability and higher omission error rates, whereas mean response speed did not differ significantly. Within the CD cohort, sustained attention was significantly associated with disease activity and was the only subdomain predicting HBI scores. Patients in clinical remission continued to show impairments in sustained and focused attention compared with controls, whereas response speed was unaffected. Conclusion: CD is associated with selective alterations in attentional stability rather than generalized slowing. Attentional variability tracks clinical activity and remains detectable during remission, suggesting that sustained attention may represent a sensitive cognitive marker of ongoing disease impact.